Suppr超能文献

在浅表躯干基底细胞癌的电干燥刮除术前和术后使用基于对苯二酚/维甲酸的皮肤护理系统:一项关于短期愈合的多中心、随机、研究者盲法、对照研究。

Using a Hydroquinone/Tretinoin-based Skin Care System Before and After Electrodesiccation and Curettage of Superficial Truncal Basal Cell Carcinoma: A Multicenter, Randomized, Investigator-blind, Controlled Study of Short-term Healing.

作者信息

David Pariser, James Spencer, Brian Berman, Suzanne Bruce, Lisa Parr, Kenneth Gross

机构信息

Department of Dermatology, Eastern Virginia Medical School and Virginia Clinical Research, Inc., Norfolk, Virginia.

出版信息

J Clin Aesthet Dermatol. 2009 May;2(5):38-43.

Abstract

OBJECTIVE

To evaluate the efficacy and tolerability of using a 4% hydroquinone/0.05% tretinoin skin care system compared with standard treatment of cleanser plus healing ointment to enhance aesthetic outcomes resulting from electrodesiccation and curettage treatment for superficial truncal basal cell carcinomas.

DESIGN

Multicenter, investigator-masked, randomized, parallel-group study. Patients received either the hydroquinone/tretinoin system or the standard treatment twice daily for three weeks before and after electrodesiccation and curettage (postelectrodesiccation and curettage, lesions received standard treatment until reepithelialization was >75 percent; assigned treatment regimens then resumed).

SETTING

Patients attending academic, institutional, and private dermatology clinics.

PARTICIPANTS

51 patients with 1 to 3 superficial truncal basal cell carcinomas.

MEASUREMENTS

The primary efficacy outcome was the incidence of treatment success for scar cosmesis, defined as a global assessment of excellent or good wound appearance (on a scale of excellent, good, fair, and poor), as evaluated by the investigators. After the end of the study, seven expert masked graders (dermatologists or plastic surgeons) reviewed the photographs from all of the lesions and also evaluated global assessment.

RESULTS

The incidence of treatment success in the hydroquinone/tretinoin and standard treatment groups was 72 percent versus 63 percent according to the masked investigators and 45 to 68 percent versus 20 to 44 percent, respectively, according to the seven expert masked graders. All the expert graders reported a higher incidence of treatment success with the hydroquinone/ tretinoin system than with standard treatment and this difference was statistically significant for five of the seven graders.

CONCLUSION

The adjunctive use of the hydroquinone/tretinoin skin care system may offer enhanced aesthetic results postelectrodesiccation and curettage compared with standard treatment. (J Clin Aesthetic Dermatol. 2009;2(5):38-43.).

摘要

目的

评估4%氢醌/0.05%维甲酸皮肤护理系统与标准治疗(洁面乳加愈合软膏)相比,在改善躯干浅表基底细胞癌电干燥刮除术后美学效果方面的疗效和耐受性。

设计

多中心、研究者设盲、随机、平行组研究。患者在电干燥刮除术前及术后3周,每天两次接受氢醌/维甲酸系统治疗或标准治疗。(电干燥刮除术后,病变部位接受标准治疗直至上皮再形成超过75%;之后恢复分配的治疗方案)。

地点

在学术、机构和私立皮肤科诊所就诊的患者。

参与者

51例患有1至3个躯干浅表基底细胞癌的患者。

测量

主要疗效指标为瘢痕美容治疗成功的发生率,定义为研究者评估的整体伤口外观为优或良(分为优、良、中、差)。研究结束后,7名设盲专家评分员(皮肤科医生或整形外科医生)查看了所有病变的照片,并进行了整体评估。

结果

根据设盲研究者评估,氢醌/维甲酸组和标准治疗组的治疗成功发生率分别为72%和63%;根据7名设盲专家评分员评估,分别为45%至68%和20%至44%。所有专家评分员均报告氢醌/维甲酸系统治疗成功的发生率高于标准治疗,7名评分员中有5名差异具有统计学意义。

结论

与标准治疗相比,氢醌/维甲酸皮肤护理系统辅助使用可能会改善电干燥刮除术后的美学效果。(《临床美容皮肤科杂志》。2009年;2(5):38 - 43。)

相似文献

9

本文引用的文献

3
Topical treatments for hypertrophic scars.
J Am Acad Dermatol. 2006 Dec;55(6):1024-31. doi: 10.1016/j.jaad.2006.03.022. Epub 2006 Sep 18.
6
Novel opportunities in the treatment and prevention of scarring.
J Cutan Med Surg. 2004;8 Suppl 3:32-6. doi: 10.1007/s10227-004-0806-0.
7
Topical agents used in the management of hyperpigmentation.
Skin Therapy Lett. 2004 Jun-Jul;9(6):1-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验